RBA Wealth Management LLC grew its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 0.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,195 shares of the semiconductor company’s stock after purchasing an additional 69 shares during the quarter. Synopsys makes up about 2.1% of RBA Wealth Management LLC’s holdings, making the stock its 13th largest position. RBA Wealth Management LLC’s holdings in Synopsys were worth $5,434,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors also recently modified their holdings of SNPS. Rheos Capital Works Inc. lifted its stake in Synopsys by 22.5% in the fourth quarter. Rheos Capital Works Inc. now owns 49,000 shares of the semiconductor company’s stock valued at $23,783,000 after purchasing an additional 9,000 shares during the last quarter. Boston Trust Walden Corp increased its holdings in shares of Synopsys by 1.2% in the fourth quarter. Boston Trust Walden Corp now owns 2,474 shares of the semiconductor company’s stock worth $1,201,000 after purchasing an additional 30 shares during the period. Magnolia Capital Advisors LLC bought a new position in Synopsys in the fourth quarter valued at $245,000. Stock Yards Bank & Trust Co. bought a new position in Synopsys in the fourth quarter valued at $710,000. Finally, Greenleaf Trust boosted its holdings in Synopsys by 8.9% during the 4th quarter. Greenleaf Trust now owns 6,909 shares of the semiconductor company’s stock valued at $3,353,000 after acquiring an additional 566 shares during the period. Institutional investors own 85.47% of the company’s stock.
Synopsys Stock Down 1.0 %
SNPS stock opened at $520.25 on Tuesday. The company has a market cap of $80.42 billion, a PE ratio of 35.83, a price-to-earnings-growth ratio of 3.44 and a beta of 1.12. The business has a 50-day simple moving average of $516.26 and a 200 day simple moving average of $519.95. Synopsys, Inc. has a 52 week low of $457.52 and a 52 week high of $629.38.
Wall Street Analyst Weigh In
Get Our Latest Research Report on Synopsys
Insider Buying and Selling at Synopsys
In other Synopsys news, CRO Richard S. Mahoney sold 20,838 shares of the company’s stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total value of $10,544,236.38. Following the completion of the transaction, the executive now owns 1,460 shares in the company, valued at $738,774.60. This represents a 93.45 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.66% of the company’s stock.
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles
- Five stocks we like better than Synopsys
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- T-Mobile: The Best Wireless Carrier Stock to Own Right Now?
- The How And Why of Investing in Oil Stocks
- Boeing: Charting a Course for Recovery and Redemption
- 3 Healthcare Dividend Stocks to Buy
- Top 3 High-Momentum Companies Analysts Are Still Bullish On
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.